SWOG S0925: A randomized phase II study of androgen deprivation combined with cixutumumab versus androgen deprivation alone in patients with new metastatic hormone-sensitive prostate cancer

Evan Y. Yu, Hongli Li, Celestia S. Higano, Neeraj Agarwal, Sumanta K. Pal, Ajjai Alva, Elisabeth I. Heath, Elaine T. Lam, Shilpa Gupta, Michael B. Lilly, Yoshio Inoue, Kim N. Chi, Nicholas J. Vogelzang, David I. Quinn, Heather H. Cheng, Stephen R. Plymate, Maha Hussain, Catherine M. Tangen, Ian M. Thompson

Resultado de la investigación: Articlerevisión exhaustiva

41 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'SWOG S0925: A randomized phase II study of androgen deprivation combined with cixutumumab versus androgen deprivation alone in patients with new metastatic hormone-sensitive prostate cancer'. En conjunto forman una huella única.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Immunology and Microbiology

Neuroscience